Single for Mitral Valve Regurgitation

Phase-Based Progress Estimates
Houston Methodist Hospital, Houston, TXMitral Valve RegurgitationHighLife Transcatheter Mitral Valve Replacment - Device
All Sexes
What conditions do you have?

Study Summary

This triallooks at the safety and performance of a transcatheter mitral valve for high-risk patients with moderate-severe and severe mitral regurgitation.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 30 days

30 days
Device Safety

Trial Safety

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Single · No Placebo Group · N/A

Experimental Group · 1 Intervention: HighLife Transcatheter Mitral Valve Replacment · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days

Who is running the clinical trial?

HighLife SASLead Sponsor
3 Previous Clinical Trials
70 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The patient's anatomy is suitable for the HighLife valve.

Frequently Asked Questions

What is the population size of this experiment?

"A total of 15 patients that meet the eligibility criteria are required for this trial and can be recruited from two separate medical institutions: Chippenham Hospital Richmond in Virginia, and University of Pennsylvania in Philadelphia." - Anonymous Online Contributor

Unverified Answer

In what number of healthcare facilities is this trial currently taking place?

"At the present moment, 8 different clinical trial sites are operational. These locations span from Richmond to Philadelphia and Charleston with other centres scattered in between. To minimize travel time, those interested should select a facility closest to them if they choose to enroll." - Anonymous Online Contributor

Unverified Answer

Is this experiment recruiting participants currently?

"Affirmative. According to, this healthcare experiment is currently in need of participants and was first posted on July 14th 2020. This study has been updated as recently as October 21st 2022 and requires 15 people between 8 sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.